Sivia Capital Partners LLC Invests $204,000 in Maximus, Inc. $MMS

Key Points

• Sivia Capital Partners LLC recently acquired a new position in Maximus, Inc., purchasing 2,905 shares valued at approximately $204,000.
• Maximus has received a strong-buy rating from Zacks Research, with the stock having a consensus price target of $90.00.
• The company also recently announced a quarterly dividend of $0.30 per share, resulting in an annualized yield of 1.3%.

Sivia Capital Partners LLC purchased a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 2,905 shares of the health services provider's stock, valued at approximately $204,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MMS. LRI Investments LLC raised its position in Maximus by 11.9% in the 1st quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock worth $125,000 after purchasing an additional 195 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock valued at $2,351,000 after buying an additional 221 shares in the last quarter. Vestcor Inc raised its stake in Maximus by 2.3% during the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after buying an additional 223 shares during the last quarter. Cetera Investment Advisers increased its stake in Maximus by 5.8% in the first quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock valued at $308,000 after purchasing an additional 247 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in shares of Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after buying an additional 250 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Price Performance

MMS traded down $0.03 on Tuesday, hitting $88.78. 80,305 shares of the company's stock were exchanged, compared to its average volume of 572,441. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.94. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The firm has a 50-day moving average price of $81.89 and a 200-day moving average price of $74.09. The stock has a market cap of $5.00 billion, a price-to-earnings ratio of 16.39 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the previous year, the firm earned $1.74 EPS. The company's quarterly revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Friday, August 15th. Maximus's payout ratio is currently 22.10%.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Strong Buy" and a consensus target price of $90.00.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.